Dr. Sandra Marchese Johnson, MD

Dr. Johnson practices at Johnson Dermatology in Fort Smith, Arkansas.

Dr. Johnson's NPI, 1447256102, was assigned on June 27, 2005. Dr. Johnson graduated from Northeastern Ohio University College of Medicine in 1996. Dr. Johnson holds Arkansas license E-1554.

Dr. Johnson's primary practice is Johnson Dermatology, at 5921 Riley Park Dr, Fort Smith, AR 72916-6103. The practice phone is (479) 649-3376.

Dr. Johnson's primary practice is Johnson Dermatology in Fort Smith, Arkansas. Dr. Johnson is also affiliated with Baptist Health Medical Center Fort Smith. The medical group on file is Johnson Dermatology. Dmand AI also links Dr. Johnson to 1 more other site, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Johnson practices, 3 sites in all. Vendor and product names are available with a free account.

Dermatology is Dr. Johnson's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Johnson is licensed in Arkansas.

CMS data shows 20,741 Medicare services from Dr. Johnson across 20 procedure codes in 2024, for 1,209 Medicare patients. Medicare paid $268,937 for them. Every service was in an office.

CMS counts 1,209 Medicare patients who saw Dr. Johnson in 2024. The largest group is 65 to 74, with 542 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 2% are also on Medicaid. Their average risk score is 1.01, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Johnson's median patient age at 70, with 61% women.

In 2024, Dr. Johnson wrote 1,412 Medicare Part D claims for 498 patients. 94% of them were for generic drugs. CMS names the drug for 1,207 of them, across 21 drugs with 11 or more claims each, at $26,635 in total drug cost. In 2023, CMS named 911 claims across 21 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 85 out of 100 for Dr. Johnson for performance year 2024, reported as part of a group. Dr. Johnson accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 1,636 procedures of removal of skin lesions by Dr. Johnson, more than 97% of the clinicians it reports for that procedure.

Dmand AI links 19 papers to Dr. Johnson, published from 2015 to 2023. 2015 was the busiest year, with 2. The most frequent topics are Rosacea, Dermatologic Agents and Doxycycline. Dr. Johnson has published most often in J Drugs Dermatol. Dr. Johnson's most frequent co-authors are James Del Rosso, DO, Edward Lewis Lain, MD and Emil Anthony Tanghetti, MD.

Dmand AI links Dr. Johnson to 11 clinical trials, 2 of them phase 3 studies. Conditions studied include Dermatitis, Atopic, Eczema and Skin Diseases, Eczematous. Eli Lilly and Company sponsors the most, 7. Open Payments lists research payments to Dr. Johnson that name 10 trials.

CMS Open Payments shows 2,033 general payments to Dr. Johnson from 42 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 72% of the total. Amgen Inc. paid the most, $147,410. It also lists 38 research payments totaling $855,779 from 2016 to 2025, naming 10 clinical trials.

Dr. Johnson graduated from Northeastern Ohio University College of Medicine in 1996.